Results 191 to 200 of about 1,946,344 (262)

Ebola virus' hidden target: virus transmission to and infection of skin. [PDF]

J Virol
Richards PT, Fleck AM, Patel R, Fakhimi M, Bohan D, Geoghegan-Barek K, Honko AN, Stolte AE, Plescia CB, Messingham CO, Connell SJ, Crowe TP, Gourronc FA, Carrion R, Griffiths A, Meyerholz DK, Klingelhutz AJ, Davey RA, Messingham KN, Maury W.   +19 more
europepmc   +1 more source

Long-Term Efficacy of Disinfectants Against Ebola Virus and Nipah Virus for Use in Containment Level 4 Laboratories. [PDF]

Viruses
Phelps AL, Eastaugh L, Findlay JS, Thom R, Lever MS, Smither SJ.   +5 more
europepmc   +1 more source

Thermal tolerance and inactivation of Ebola virus. [PDF]

Virol Sin
Gao X, Peng C, Pei R.
europepmc   +1 more source

Risk behaviour associated with contracting the Ebola virus at funerals: a study of Liberians attending the funerals of individuals deceased from Ebola. [PDF]

Front Public Health
Stephens MT, Tangmunkongvorakul A, Kosashunhanan N, Fallah M, Gilayeneh JSM, Kie T, Srithanaviboonchai K.   +6 more
europepmc   +1 more source

Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence. [PDF]

Proc Natl Acad Sci U S A
Yamaoka S, M'Hamdi Z, Wang L, Swenson VA, McNally KL, Lu SC, Singh R, Saundh SL, Zell BN, Best SM, Barry MA, Rasmussen AL, Ebihara H.   +12 more
europepmc   +1 more source

Platelet-like particles released from Ebola virus-infected megakaryocytic cells behave like virus-like particles. [PDF]

PLoS Pathog
Kuroda M, Halfmann PJ.
europepmc   +1 more source

Long-term Sequelae in Ebola Virus Disease Survivors Receiving Anti-Ebola Virus Therapies in the Democratic Republic of the Congo: A Prospective Cohort Study. [PDF]

Open Forum Infect Dis
Dilu-Keti A, Tovar-Sanchez T, Cuer B, Nkuba-Ndaye A, Mukadi-Bamuleka D, Panzi-Kalunda E, Kitenge-Omasumbu R, Bulabula-Penge J, Mambu-Mbika F, Mbala-Kingebeni P, Ayouba A, Muyembe-Tamfum JJ, Etard JF, Chenge F, Delaporte E, Ahuka-Mundeke S, ‘Les Vainqueurs d’Ebola’ study group .   +16 more
europepmc   +1 more source

Small molecule drug discovery for Ebola virus disease. [PDF]

RSC Med Chem
Durante D, Murugesh V, Kalanquin T, Gaisina IN, Rong L, Moore TW.   +5 more
europepmc   +1 more source

Long-term psychosocial sequelae of Ebola virus disease among survivors compared with contacts following the 2013-2016 epidemic in Liberia. [PDF]

PLOS Glob Public Health
Badio M, Glayweon M, Van Ryn C, Wilson B, Cooper JB, Moses JS, Fayiah T, Johnson K, Gayedyu-Dennis D, Chitre SD, Richardson ET, Reilly C, Weiser SD, Rutherford GW, Fallah MP, Kelly JD.   +15 more
europepmc   +1 more source

Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report

New England Journal of Medicine, 2017
G. Deen, N. Broutet, Wenbo Xu, B. Knust, F. Sesay, S. L. McDonald, E. Ervin, J. Marrinan, P. Gaillard, N. Habib, Hongtu Liu, William J. Liu, A. Thorson, F. Yamba, T. Massaquoi, Faustine James, A. Ariyarajah, C. Ross, K. Bernstein, A. Coursier, J. Klena, M. Carino, Alie H. Wurie, Yong Zhang, Marion S. Dumbuya, Neetu Abad, Baimba Idriss, T. Wi, S. Bennett, Tina Davies, F. Ebrahim, E. Meites, D. Naidoo, S. Smith, Patricia Ongpin, Tasneem Malik, Anshu Banerjee, B. Erickson, Yongjian Liu, Yang Liu, Kexin Xu, A. Brault, K. Durski, J. Winter, Tara K. Sealy, S. Nichol, M. Lamunu, J. Bangura, S. Landoulsi, A. Jambai, O. Morgan, Guizhen Wu, M. Liang, Q. Su, Y. Lan, Yanzhe Hao, P. Formenty, U. Ströher, F. Sahr   +58 more
semanticscholar   +1 more source